Globus Medical Launches MONUMENT Anterior Spondylolisthesis Reduction System

AUDUBON, Pa.--()--Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced the launch of MONUMENT™, a unique anterior lumbar interbody fusion device with a built-in mechanical feature designed to aid in spondylolisthesis reduction. The self-locking and threaded translational feature can be engaged to reduce the implant up to 8mm in situ and the screws are designed for optimal cortical purchase.

“MONUMENT™, with its threaded translational reduction feature, is designed to be more efficient for the surgeon by incorporating mechanized implant reduction with an integrated plate-spacer. Alternative procedures require additional steps in treating this challenging condition. Our new system includes all the benefits typical of an anterior lumbar interbody spacer with a large stabilizing surface area and large graft window to optimize fusion,” commented Andrew Iott, Senior Vice President of Product Development.

“The implant’s translational reduction feature performs exceptionally well. MONUMENT™ offers the benefits of an integrated ALIF system and simple, intuitive instruments combined with in-situ implant reduction, making it an attractive surgical solution for patients with spondylolisthesis,” commented Christopher Tomaras, MD, Neurosurgeon at Peachtree Neurosurgery in Atlanta, Georgia.

The MONUMENT™ Spacer is available in different sizes, heights and sagittal angles to accommodate the lumbar and sacral spine, including L5-S1. The device is intended for use with supplemental fixation.

About Globus Medical, Inc.

Globus Medical, Inc. is a leading musculoskeletal implant company based in Audubon, PA. The company was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients with musculoskeletal disorders. Additional information can be accessed at www.globusmedical.com.

Safe Harbor Statements

All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with changing laws and regulations that are applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the Securities and Exchange Commission. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.

Contacts

Globus Medical, Inc.
Ed Joyce, 610-930-1800
investors@globusmedical.com
www.globusmedical.com

MONUMENT Anterior Spondylolisthesis Reduction System. Credit: Globus Medical

???news_view.multimedia.download???

???pagination.previous??? ???pagination.next???

Sharing

Contacts

Globus Medical, Inc.
Ed Joyce, 610-930-1800
investors@globusmedical.com
www.globusmedical.com